FineHeart
PrivateLast Round
Series C
Jan 9, 2026
Total Funding Raised
$75.41M
Company Overview
FineHeart is a medical device company that has developed the FLOWMAKER®, a novel, wirelessly powered, fully implantable mechanical circulatory support device for severe heart failure patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FineHeart Comps
Public and private peers based on sector, stage, and business model.
FineHeart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 9, 2026 | ||||
| Grant | Oct 19, 2022 | ||||
| Series B Extension | Dec 15, 2021 | ||||
| Series B | Jun 1, 2021 | ||||
| Series A | Mar 21, 2016 |
FineHeart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Series C |
| Verve Ventures | Series B Extension, Series B |
| IRDInov | Series A |
| European Commission | Grant |
| Verve Capital | Series C |
| Aqui-Invest | Series A |
| Groupe Pasteur Mutualité | Series C |
FineHeart Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FineHeart's valuation, stock price, and market status.